UPDATE: 9 Meters Biopharma (NMTR) Prices 46.154M Share Common Offering at $0.65/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. DCOY
6. MSFT
7. VKTX
8. PRGS
9. LGND
10. INNV

Go back to UPDATE: 9 Meters Biopharma (NMTR) Prices 46.154M Share Common Offering at $0.65/Sh

After-Hours Stock Movers 12/10: (TPGY) (GIK) (RMG) Higher; (AMPY) (NBRV) (QCOM) Lower (more...)

December 10, 2020 6:06 PM EST

Today's After-Hours Stock Movers:

TPG Pace Beneficial Finance Corp. (NYSE: TPGY) 75% HIGHER; entered into a definitive agreement with ENGIE New Business S.A.S., a wholly owned subsidiary of ENGIE S.A. (Engie), a multi-national utility with headquarters in France, to acquire its subsidiary EV Charged B.V. for a combination of cash and equity. EVBox is a leading global provider of smart charging solutions for electric vehicles with Europes largest installed base of charging solutions and the most advanced cloud-based software offering.

Amplify Energy Corp. (NYSE:... More

9 Meters Biopharma (NMTR) Announces Proposed Public Offering of Common Stock

December 10, 2020 5:07 PM EST

9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, announced today that it has commenced a proposed underwritten public offering of shares of its common stock. In connection with this offering, 9 Meters Biopharma expects to grant the underwriters a 30-day option... More

9 Meters Biopharma (NMTR) Receives Orphan Drug Designation for NM-003, Proprietary Long-Acting GLP-2, for Prevention of aGvHD

December 9, 2020 7:38 AM EST

9 Meters Biopharma, Inc. (NASDAQ: NMTR), a clinical-stage rare and unmet needs-focused gastroenterology company, today announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to NM-003, a proprietary long-acting GLP-2 receptor agonist, for prevention of acute graft versus host... More